Skip to main content
OpenTrials

Clinical trial condition

Congenital Hyperinsulinism

Explore clinical trials studying Congenital Hyperinsulinism. Study availability and eligibility vary by location and protocol.

17 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Congenital Hyperinsulinism trial results

Active, not recruiting

HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)

NCT04732416

Conditions
Congenital Hyperinsulinism, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +7 more
Locations
  • The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Otto-von-Guericke-Universitaet Magdeburg Magdeburg, Germany
  • Hadassah Medical Center (HMC) Jerusalem, Israel
  • Pusan National University Yangsan Hospital Pusan, South Korea
View Trial Details
Active, not recruiting

RZ358 Treatment for Congenital Hyperinsulinism

NCT06208215

Conditions
Congenital Hyperinsulinism, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +7 more
Locations
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Cook Children's Medical Center Fort Worth, Texas, United States
  • Rezolute Investigative Site, Varna, Bulgaria Varna, Bulgaria
  • Rezolute Investigative Site, Odense, Denmark Odense, Denmark
View all 18 locations
View Trial Details
Completed

Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism

NCT03941236

Conditions
Congenital Hyperinsulinism, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +7 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Cook Children's Endocrinology and Diabetes Clinic Fort Worth, Texas, United States
  • University Hospital Düsseldorf, Department of Pediatrics Düsseldorf, Germany
View Trial Details
Completed

An Open-Label Multiple Dose Study of RZ358 in Patients With Congenital Hyperinsulinism

NCT04538989

Conditions
Congenital Hyperinsulinism, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +7 more
Locations
  • The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Cook Children's Medical Center Fort Worth, Texas, United States
  • SHAT Children diseases "Prof. Dr. Ivan Mitov" Sofia, Bulgaria
  • Medical University of Varna UMHAT "St. Marina" Varna, Bulgaria
View all 17 locations
View Trial Details
Completed

Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism

NCT04172441

Conditions
Congenital Hyperinsulinism, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +7 more
Locations
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Cook Children's Medical Center Fort Worth, Texas, United States
  • University Children's Hospital Düsseldorf, Germany
  • University Hospital, Magdeburg Magdeburg, Germany
View Trial Details
Completed

A Two-Period Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism

NCT03777176

Conditions
Congenital Hyperinsulinism, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +7 more
Locations
  • Children's Hospital of Colorado Aurora, Colorado, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Cook Children's Medical Center Fort Worth, Texas, United States
  • University Hospital Düsseldorf, Department of Pediatrics Düsseldorf, Germany
View Trial Details

Related conditions